ResidentAbstract # 10Tony NgTony Ng 1,2 , Matthew Robertson 1 , Hao Zhu3, William Einhorn 3 , George Daley 3 ,Poul Sorensen 1,21Department of Molecular Oncology, BC Cancer Research Centre, 2 Department of <strong>Pathology</strong><strong>and</strong> <strong>Laboratory</strong> <strong>Medicine</strong>, <strong>University</strong> of British Columbia, Vancouver, BC <strong>and</strong> 3 Children’sHospital Boston, Harvard Medical School, Boston, MAidentification <strong>and</strong> characterization of a novel TCF12-LIN28B fusion in sporadic Wilms’ tumorBackround/ObjectivesWilms’ tumor (WT) is the most common form of pediatric renal cancer; however, the genetics underlying thesporadic form of WT remain largely unknown. We recently characterized chromosome 6q21 breakpoints in twoindependent sporadic WT cases with t(6;15) translocations in an otherwise cytogenetically normal background. Inboth cases, we mapped the 6q21 breakpoints to an intergenic region between the HACE1 <strong>and</strong> LIN28B genes; thechromosome 15 breakpoint mapped to the TCF12 gene. LIN28B has been shown to have oncogenic propertiesthrough its ability to bind let-7 microRNAs (miRNAs) <strong>and</strong> reverse let-7 inhibition of multiple oncogenic pathwayssuch as Ras <strong>and</strong> c-Myc. Furthermore, 6q21 rearrangements in the region of the LIN28B locus may be recurrent inWT based on multiple case reports in WT. We hypothesized that these t(6;15) translocations lead to the generation ofa fusion transcript between TCF12 <strong>and</strong> LIN28B with oncogenic properties.MethodsRT-PCR <strong>and</strong> sequencing was used to identify a putative TCF12-LIN28B fusion in WT samples. This fusion wascloned <strong>and</strong> expressed in NIH/3T3 <strong>and</strong> HEK293T cell lines for biochemical studies, including assays of let-7 levels,levels of let-7 targets, <strong>and</strong> transformation assays.ResultsAnalysis of the index t(6;15) WT case by RT-PCR confirmed expression of a TCF12-LIN28B fusion transcript.Cloning <strong>and</strong> sequencing of the coding region of the full-length transcript showed fusion of exons 1-5 of TCF12to exons 2-4 of LIN28B. RT-PCR for the fusion in the second t(6;15) case also demonstrated expression of thesame fusion transcript, but was not detected in a small series of 10 other WT cases. When TCF12-LIN28B wasoverexpressed in NIH/3T3 cells, multiple let-7 miRNA family members were suppressed to a level similar to thatseen with wild-type LIN28B overexpression. To establish the transformation ability of this fusion, we used the HEK-293T human embryonic kidney cell line to serve as a more relevant WT model. Again, akin to that seen with wildtypeLIN28B, overexpression of TCF12-LIN28B in HEK-293T indeed promoted anchorage-independent growthin the soft agar colony assay. Furthermore, multiple let-7 targets are elevated in TCF12-LIN28B overexpressing cellscompared to control cells at the protein level, including K-Ras <strong>and</strong> c-Myc. Paradoxically, the mitogenic response ofboth TCF12-LIN28B <strong>and</strong> LIN28B overexpressing cells to serum stimulation are reduced, based on levels of pERK<strong>and</strong> pMEK, <strong>and</strong> pAkt to a lesser extent, as readouts of Ras pathway signalling.ConclusionWe identified a novel TCF12-LIN28B fusion gene in WT in the context of two cases bearing t(6;15) translocations.TCF12-LIN28B appears to possess oncogenic properties similar to wild-type LIN28B through their ability to modifylet-7 miRNA levels <strong>and</strong> their downstream targets. Further studies are needed to determine the incidence of this fusionin WT <strong>and</strong> other cancers, <strong>and</strong> to elucidate the mechanisms by which it promotes WT tumorigenesis.20 2 0 1 0 * O r a l P r e s e n t a t i o n s
ResidentMajid Zolein 1 , Daniel T. Holmes 1,21Department of <strong>Pathology</strong> <strong>and</strong> <strong>Laboratory</strong> <strong>Medicine</strong>, <strong>University</strong> of British Columbia, 2 St.Paul’s Hospital Department of <strong>Pathology</strong> <strong>and</strong> <strong>Laboratory</strong> <strong>Medicine</strong>Abstract # 11a performance audit of adrenal vein sampling inbritish columbia: how are we doing?Majid ZoleinBackround/ObjectivesPrimary Aldosteronism (PA) is a treatable <strong>and</strong> often curable form of secondary hypertension affecting up to 10% ofindividuals who have a diagnosis of high blood pressure. Causes include, aldosterone producing adenoma (Conn’sSyndrome), bilateral adrenal hyperplasia, glucocorticoid remediable hypertension, <strong>and</strong> other rare forms.Because aldosteronomas are generally small, CT scan is unreliable to locate tumors. Therefore, once PA has beenclinically proven by provocative studies, Adrenal Vein Sampling (AVS) is used to determine if there is lateralizationof aldosterone production to one adrenal or the other. Success in AVS is technically hampered by the anatomy of theright adrenal vein which inserts directly into the IVC.Our objective was to audit the utility <strong>and</strong> success of AVS procedures in BC <strong>and</strong> to evaluate commonly employedbiochemical criteria for catheterization success. .MethodsThis was a retrospective audit of 90 cases of AVS which occurred from 2003-2010. Result of adrenal venous <strong>and</strong>peripheral venous cortisol <strong>and</strong> aldosterone were extracted from Vancouver Coastal laboratory information systems.All cases were systematically reviewed <strong>and</strong> calculations performed by st<strong>and</strong>ard approaches. Statistical analysis wasperformed using R (www.r-project.org).ResultsNumerous patients who did not have proven PA underwent the AVS procedure. Some patients had peripheral venousaldosterone results that actually excluded a diagnosis of PA. There was a statistically significant difference in the successrate of radiological operators with some having cannulation success rates of the right adrenal vein as low as 30%.St<strong>and</strong>ard published biochemical catheterization criteria occasionally failed. ACTH stimulation during the procedureassisted in proving catheterization but obscured results on occasion. AVS helped localize adenomas that eluded CT<strong>and</strong> also helped identify some tumors as incidentaloma. CT prior to AVS assists in identifying anatomical variants.ConclusionAVS should be performed by a minimum number of operators. AVS utility in BC is inconsistent due to frequentlyfailed cannulation of the right adrenal vein. All patients who undergo the procedure should have PA proven by aprovocative test, with the exception of extreme presentations. ACTH stimulation during AVS is generally helpfulprovided its limitations are understood.<strong>Oral</strong> <strong>Presentations</strong> * 2 0 1 021
- Page 2: PathDay: Keynote Speaker (4:30 pm)T
- Page 5: Conference Outline2010abstract #14
- Page 9 and 10: Table of Contentabstract #57 The ro
- Page 11 and 12: ResidentClinical SciencesArwa Al-Ri
- Page 13 and 14: ResidentTitus Wong 1 , Marc Romney,
- Page 17 and 18: ResidentD. Turbin 1 , D. Gao 2 , J.
- Page 19: ResidentDavid F Schaeffer 1 , Eric
- Page 23 and 24: Graduate StudentAshish K. Marwaha 1
- Page 25 and 26: Graduate StudentAmanda Vanden Hoek
- Page 27 and 28: Graduate StudentXin Ye 1 , Mary Zha
- Page 29: Graduate StudentLisa S. Ang 1 , Sar
- Page 32 and 33: Graduate StudentAbstract # 22Brian
- Page 36 and 37: OtherAbstract # 25Crystal Leung, Li
- Page 38 and 39: OtherAbstract # 27Lise Matzke 1 , W
- Page 40 and 41: Graduate StudentAbstract # 29Varun
- Page 42 and 43: Graduate StudentAbstract # 31Maite
- Page 44 and 45: Post-doctoral FellowAbstract # 33Ra
- Page 46 and 47: Graduate StudentAbstract # 35Hayley
- Page 48: Post-doctoral FellowAbstract # 37Es
- Page 51 and 52: ResidentAhmad Al-Sarraf MD 1, 2 , G
- Page 53 and 54: OtherRebecca Towle 1 , Danielle Mac
- Page 55 and 56: Graduate StudentPaul R. Hiebert 1,2
- Page 57 and 58: Graduate StudentV. Montoya 1 , J. G
- Page 59 and 60: OtherWalter Martz and Henry Kalicia
- Page 61 and 62: OtherKatelyn J. Janzen 1 , Elizabet
- Page 63 and 64: Graduate StudentJasmine L. Hamilton
- Page 65 and 66: Graduate StudentIan M. Wilson 1 , K
- Page 67 and 68: Graduate StudentKelsie L. Thu 1,3 ,
- Page 69 and 70: OtherLiat Apel-Sarid 1 , Doug Cochr
- Page 71 and 72:
Graduate StudentJennifer R. Choo 1,
- Page 73 and 74:
Graduate StudentEdwin S. Gershom 1
- Page 75 and 76:
OtherYing Qiao 1, 2 , Chansonette H
- Page 77 and 78:
Graduate StudentLeslie YM Chin 1,4
- Page 79 and 80:
Graduate StudentBillie Velapatiño
- Page 81 and 82:
Graduate StudentSophie Stukas 1 , S
- Page 83 and 84:
Graduate StudentKyluik DL and Scott
- Page 85 and 86:
Post-doctoral FellowJoel Montane 1
- Page 87 and 88:
IndexAAbozina A. 45Abraham T. 55All
- Page 89:
Ye X. 27, 82Yee S. 31Yoshida E. 12Y